Realkredit Danmark A/S
22.2.2021 15:32:34 CET | Globenewswire | Press release
This republication is made due a wrong categorisation, which is now correct. At 14.48 CET the correct publication was sent.
Realkredit Danmark will open a new callable fixed-rate mortgage covered bond (SDRO) with the following characteristics:
| Coupon | Series | Amortisation | Closing date | Maturity |
| 1.50% | 28S | Annuity* | 31-08-2023 | 01-10-2053 |
*) with option on up to 30 years interest only.
The mortgage covered bond will be issued in DKK from Capital Centre S. The mortgage covered bond will be used to fund loans with maturities up to 30 years.
The final terms of the bond will be published by announcement of prospectus as soon as they are available.
The Executive Board
Any additional questions should be addressed to Chief analyst, Hella Gebhardt Rønnebæk, phone +45 45 13 20 68.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Aalborg Boldspilklub A/S18.3.2026 13:08:05 CET | Pressemeddelelse
Spar Nord Bank A/S og AaB A/S ophæver Market Maker-aftale
Acronis, Inc.18.3.2026 13:00:00 CET | Press release
Acronis Appoints Mark Wong as Chief Corporate & Business Development Officer
ProMIS Neurosciences Inc.18.3.2026 13:00:00 CET | Press release
ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer’s Disease/Parkinson’s Disease 2026 International Conference (AD/PD™)
Merck18.3.2026 13:00:00 CET | Press release
Merck Marks 10 Years of SPARK™ Mobilizing Employee Volunteers to Help Inspire the Next Generation in STEM
Amphista Therapeutics18.3.2026 13:00:00 CET | Press release
Amphista Therapeutics appoints Louise Modis Ph.D. as CEO and Patrick Kelly M.D. as CMO and provides a business update as the Company prepares to file IND application for AMX-883
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
